{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:34:23Z","timestamp":1780652063962,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.canrad.2021.06.016","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:04:44Z","timestamp":1626343484000},"page":"779-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"P.","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goudjil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.06.016_bib0160","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC\/LYSA\/FIL H10 Trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol [Internet]"},{"key":"10.1016\/j.canrad.2021.06.016_bib0165","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2021.06.016_bib0170","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.016_bib0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4329\/wjr.v3.i3.66","article-title":"Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties","volume":"3","author":"Kirova","year":"2011","journal-title":"World J Radiol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0180","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/0284186X.2018.1512153","article-title":"Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy","volume":"58","author":"Edvardsson","year":"2019","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.canrad.2021.06.016_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13014-020-1462-2","article-title":"Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction","volume":"15","author":"Scorsetti","year":"2020","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.canrad.2021.06.016_bib0195","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","article-title":"Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study","volume":"89","author":"Hoppe","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.016_bib0200","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/bjc.2017.476","article-title":"High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors","volume":"118","author":"de Vries","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2021.06.016_bib0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","article-title":"Breast cancer risk after radiation therapy for hodgkin lymphoma: influence of gonadal hormone exposure","volume":"99","author":"Krul","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.016_bib0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","article-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment","volume":"2016","author":"van Leeuwen","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.canrad.2021.06.016_bib0215","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2021.06.016_bib0220","first-page":"922","article-title":"Protontherapy versus best photon for mediastinal Hodgkin lymphoma: dosimetry comparison and treatment using ILROG guidelines","volume":"23","author":"Abbassi","year":"2019","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.prro.2019.01.006","article-title":"Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?","volume":"9","author":"Ntentas","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2007.14.4329","article-title":"Should randomized clinical trials be required for proton radiotherapy?","volume":"26","author":"Goitein","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0235","first-page":"1","article-title":"Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy","author":"Loap","year":"2021","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.canrad.2021.06.016_bib0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-014-3149-6","article-title":"Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients","volume":"148","author":"Mast","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.canrad.2021.06.016_bib0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clon.2018.01.017","article-title":"A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain","volume":"30","author":"Ranger","year":"2018","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.canrad.2021.06.016_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2020.02.025","article-title":"4D strategies for lung tumors treated with hypofractionated scanning proton beam therapy: Dosimetric impact and robustness to interplay effects","volume":"146","author":"Mastella","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0255","first-page":"79","article-title":"High-dose hypofractionated pencil beam scanning carbon ion radiotherapy for lung tumors: Dosimetric impact of different spot sizes and robustness to interfractional uncertainties","volume":"85","author":"Mastella","year":"2021","journal-title":"Phys Medica Eur J Med Phys"},{"key":"10.1016\/j.canrad.2021.06.016_bib0260","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(18)30903-3","article-title":"Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study","volume":"20","author":"Bright","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0265","series-title":"La protonth\u00e9rapie, indications et capacit\u00e9 de traitement, juin 2016, appui \u00e0 la d\u00e9cision","author":"Minsat","year":"2016"},{"key":"10.1016\/j.canrad.2021.06.016_bib0270","series-title":"Cost-effectiveness of proton therapy for young adults with mediastinal lymphoma: analysis of an institutional cohort. In: Klinische P\u00e4diatrie [Internet]","author":"Vega","year":"2020"},{"key":"10.1016\/j.canrad.2021.06.016_bib0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0280","first-page":"16","article-title":"Health Impacts of Low-Dose Ionizing Radiation: Current Scientific Debates and Regulatory Issues","author":"Vaiserman","year":"2018","journal-title":"Dose-Response [Internet]"},{"key":"10.1016\/j.canrad.2021.06.016_bib0285","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.prro.2019.09.015","article-title":"The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era","volume":"10","author":"Hoppe","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0290","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","article-title":"Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction","volume":"98","author":"Hahn","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.016_bib0295","doi-asserted-by":"crossref","first-page":"103121","DOI":"10.1016\/j.critrevonc.2020.103121","article-title":"Cardiotoxicity in breast cancer patients treated with radiation therapy: From evidences to controversies","volume":"156","author":"Loap","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2021.06.016_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","article-title":"Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention","volume":"195","author":"Piroth","year":"2019","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.canrad.2021.06.016_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.09.044","article-title":"Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy","author":"Loap","year":"2020","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:33:32Z","timestamp":1761136412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1278321821001153"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.016","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}